Home | The path of yeast resistance
The pharma industry briefing
A resolution for the new decade: resolve the US opioid crisis
Precision medicine: what barriers remain?
Can recyclable packaging turn the pharma industry green?
Phoenix Company Insight
Vertex’s Trikafta: treating the genetic basis of cystic fibrosis
Accurate Biometrics Company Insight
Q&A: talking innovation with the Association for the Cannabinoid Industry
Yeast of burden: how to develop better antifungal drugs
Loose lips bring risks: protecting pharma against leaks and fraud
Why are patients struggling to access life-saving immune globulin?
Deals in brief powered by GlobalData
Nolato Company Insight
The key list powered by GlobalData